Literature DB >> 26373704

Lipid composition has significant effect on targeted drug delivery properties of NGR-modified liposomes.

Jun Chen1, Aihua Lin2, Pei Peng2,3, Yong Wang1, Wei Gu1, Yiming Liu2.   

Abstract

The Asn-Gly-Arg (NGR) motif has previously been demonstrated to specifically bind to CD13, which is selectively overexpressed in tumor vasculature and some tumor cells (e.g. HT1080). It was reported that NGR-modified stealth liposomes (NGR-SL) could be prepared with different lipid composition, such as 1,2-dipalmitoyl-sn-glycero-phosphatidylcholine (DPPC), hydrogenated soy posphatidylcholine (HSPC) and soy posphatidylcholine (SPC). In the present study, NGR-modified liposomes were prepared with DPPC, HSPC, SPC or the mixture of HSPC and SPC. The resultant liposomes with different lipid composition were compared in terms of cell uptake, antitumor efficacy and targeted drug delivery efficiency using HT1080 tumor model. It was found that NGR-SL composed of the mixture of HSPC and SPC was able to improve targeted drug delivery efficiency to tumor producing the most significant antitumor activity. Collectively, the NGR-modified liposomes composed of the mixture of HSPC and SPC are promising carriers for the treatment of tumor. Besides NGR ligand, lipid composition could also significantly affect the targeted delivery efficiency to the tumor.

Entities:  

Keywords:  Active targeting; NGR; lipid composition; liposomes; tumor

Mesh:

Substances:

Year:  2015        PMID: 26373704     DOI: 10.3109/10717544.2015.1088598

Source DB:  PubMed          Journal:  Drug Deliv        ISSN: 1071-7544            Impact factor:   6.419


  4 in total

Review 1.  Anticancer activities of phytoconstituents and their liposomal targeting strategies against tumor cells and the microenvironment.

Authors:  Jing Zhang; Xiang Li; Leaf Huang
Journal:  Adv Drug Deliv Rev       Date:  2020-05-28       Impact factor: 15.470

Review 2.  "Fusion and binding inhibition" key target for HIV-1 treatment and pre-exposure prophylaxis: targets, drug delivery and nanotechnology approaches.

Authors:  Tanushree Malik; Gaurav Chauhan; Goutam Rath; R S R Murthy; Amit K Goyal
Journal:  Drug Deliv       Date:  2017-11       Impact factor: 6.419

3.  Long-Circulating Curcumin-Loaded Liposome Formulations with High Incorporation Efficiency, Stability and Anticancer Activity towards Pancreatic Adenocarcinoma Cell Lines In Vitro.

Authors:  Mohamed Mahmud; Adriana Piwoni; Nina Filipczak; Martyna Janicka; Jerzy Gubernator
Journal:  PLoS One       Date:  2016-12-09       Impact factor: 3.240

4.  Enhanced biological activity of liposomal methylated resveratrol analog 3'-hydroxy-3,4,5,4'-tetramethoxystilbene (DMU-214) in 3D patient-derived ovarian cancer model.

Authors:  Andrzej Nowicki; Dariusz Wawrzyniak; Mikołaj Czajkowski; Małgorzata Józkowiak; Michał Pawlak; Marcin Wierzchowski; Katarzyna Rolle; Paulina Skupin-Mrugalska; Hanna Piotrowska-Kempisty
Journal:  Drug Deliv       Date:  2022-12       Impact factor: 6.819

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.